DK160805C - Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper - Google Patents
Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramperInfo
- Publication number
- DK160805C DK160805C DK213484A DK213484A DK160805C DK 160805 C DK160805 C DK 160805C DK 213484 A DK213484 A DK 213484A DK 213484 A DK213484 A DK 213484A DK 160805 C DK160805 C DK 160805C
- Authority
- DK
- Denmark
- Prior art keywords
- illnesses
- pharmaceutical agent
- against diseases
- fight against
- dimethylglycine
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 abstract 2
- 206010015037 epilepsy Diseases 0.000 abstract 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 108010077895 Sarcosine Proteins 0.000 abstract 1
- 108700003601 dimethylglycine Proteins 0.000 abstract 1
- 229960002449 glycine Drugs 0.000 abstract 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 abstract 1
- 229940043230 sarcosine Drugs 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838311804A GB8311804D0 (en) | 1983-04-29 | 1983-04-29 | Treatment of seizure disorders and pharmaceutical compositions |
| GB8311804 | 1983-04-29 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK213484D0 DK213484D0 (da) | 1984-04-27 |
| DK213484A DK213484A (da) | 1984-10-30 |
| DK160805B DK160805B (da) | 1991-04-22 |
| DK160805C true DK160805C (da) | 1991-10-07 |
Family
ID=10541938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK213484A DK160805C (da) | 1983-04-29 | 1984-04-27 | Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4540582A (member.php) |
| EP (1) | EP0124091B1 (member.php) |
| JP (1) | JPS59206309A (member.php) |
| AT (1) | ATE48759T1 (member.php) |
| AU (1) | AU563291B2 (member.php) |
| CA (1) | CA1228818A (member.php) |
| DE (1) | DE3480764D1 (member.php) |
| DK (1) | DK160805C (member.php) |
| GB (2) | GB8311804D0 (member.php) |
| GR (1) | GR81966B (member.php) |
| IE (1) | IE57286B1 (member.php) |
| IL (1) | IL71650A (member.php) |
| NZ (1) | NZ207962A (member.php) |
| PT (1) | PT78492B (member.php) |
| ZA (1) | ZA843032B (member.php) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1192892A (en) * | 1992-01-10 | 1993-08-03 | Natalya Mikhailovna Burbenskaya | Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
| CA2327285C (en) * | 1998-05-15 | 2005-06-14 | Warner-Lambert Company | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| US6057368A (en) * | 1998-08-05 | 2000-05-02 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| US6541520B1 (en) | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
| US6395783B1 (en) | 2000-10-23 | 2002-05-28 | Brookhaven Science Associates, Llc | Treatment of PCP addiction and PCP addiction-related behavior |
| US6713497B1 (en) * | 2003-03-17 | 2004-03-30 | Brookhaven Science Associates, Llc | Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals |
| US20090017047A1 (en) * | 2004-06-11 | 2009-01-15 | Egon Tech | Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders |
| RU2007130941A (ru) * | 2005-01-14 | 2009-02-20 | Н.В. Органон (Nl) | Ингибиторы повторного поглощения глицина для лечения зависимости от наркотиков и алкоголя |
| US20160151316A1 (en) * | 2012-01-27 | 2016-06-02 | Catalyst Pharmaceutical Partners | Method of treating tourette's disorder with gaba-aminotransferase inactivators |
| US10226442B2 (en) * | 2017-07-10 | 2019-03-12 | Syneurx International (Taiwan) Corp. | Lithium salts of N-substituted glycine compounds and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1111433A (en) * | 1965-08-25 | 1968-04-24 | Zoja Lab Chim Farm | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions |
| US3960927A (en) * | 1975-03-18 | 1976-06-01 | Richardson-Merrell Inc. | Olefinic derivatives of amino acids |
| FR2437834A1 (fr) * | 1978-10-04 | 1980-04-30 | Lejeune Jerome | Compositions pharmaceutiques a base de l-serine ou de glycine |
| GB2120244B (en) * | 1982-05-17 | 1985-05-01 | Merrell Toraude & Co | Aminoalkadiene derivative |
-
1983
- 1983-04-29 GB GB838311804A patent/GB8311804D0/en active Pending
-
1984
- 1984-03-28 US US06/594,079 patent/US4540582A/en not_active Expired - Lifetime
- 1984-04-05 AU AU26443/84A patent/AU563291B2/en not_active Expired
- 1984-04-24 ZA ZA843032A patent/ZA843032B/xx unknown
- 1984-04-25 GB GB08410504A patent/GB2138680B/en not_active Expired
- 1984-04-26 NZ NZ207962A patent/NZ207962A/en unknown
- 1984-04-26 AT AT84104705T patent/ATE48759T1/de not_active IP Right Cessation
- 1984-04-26 PT PT78492A patent/PT78492B/pt unknown
- 1984-04-26 CA CA000452890A patent/CA1228818A/en not_active Expired
- 1984-04-26 DE DE8484104705T patent/DE3480764D1/de not_active Expired - Lifetime
- 1984-04-26 IL IL71650A patent/IL71650A/xx not_active IP Right Cessation
- 1984-04-26 EP EP84104705A patent/EP0124091B1/en not_active Expired
- 1984-04-27 DK DK213484A patent/DK160805C/da not_active IP Right Cessation
- 1984-04-27 GR GR74533A patent/GR81966B/el unknown
- 1984-04-27 JP JP59084236A patent/JPS59206309A/ja active Granted
- 1984-04-27 IE IE1048/84A patent/IE57286B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US4540582A (en) | 1985-09-10 |
| PT78492A (en) | 1984-05-01 |
| IE841048L (en) | 1984-10-29 |
| DK213484A (da) | 1984-10-30 |
| DK213484D0 (da) | 1984-04-27 |
| AU2644384A (en) | 1984-11-01 |
| GB2138680A (en) | 1984-10-31 |
| ATE48759T1 (de) | 1990-01-15 |
| IL71650A0 (en) | 1984-07-31 |
| GB2138680B (en) | 1986-05-21 |
| EP0124091A3 (en) | 1987-10-07 |
| EP0124091A2 (en) | 1984-11-07 |
| EP0124091B1 (en) | 1989-12-20 |
| DK160805B (da) | 1991-04-22 |
| GB8311804D0 (en) | 1983-06-02 |
| NZ207962A (en) | 1986-12-05 |
| JPS59206309A (ja) | 1984-11-22 |
| AU563291B2 (en) | 1987-07-02 |
| ZA843032B (en) | 1984-11-28 |
| IE57286B1 (en) | 1992-07-15 |
| DE3480764D1 (de) | 1990-01-25 |
| PT78492B (en) | 1986-06-11 |
| JPH0527606B2 (member.php) | 1993-04-21 |
| GB8410504D0 (en) | 1984-05-31 |
| CA1228818A (en) | 1987-11-03 |
| IL71650A (en) | 1988-07-31 |
| GR81966B (member.php) | 1984-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3579891D1 (de) | N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung. | |
| MX9203263A (es) | Composicion farmaceutica analgesica para administracion nasal. | |
| DK160805C (da) | Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper | |
| DK0869808T3 (da) | Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation | |
| DK0600010T3 (da) | Anvendelse af relaxin til fremstilling af et medikament til behandling af cardiovaskulære sygdomme | |
| ES2165990T3 (es) | Thip para el tratamiento de trastornos del sueño. | |
| DK0738152T3 (da) | Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer | |
| DK0840606T3 (da) | Små di- og trivalente molekyler som selectininhibitorer | |
| PT1100805E (pt) | Sais de nitrato medicinais | |
| FI845133A7 (fi) | Vaikutusainetta luovuttavia systeemejä. | |
| RU94031161A (ru) | Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов | |
| DK0994704T3 (da) | Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme | |
| ES2195655T3 (es) | Procedimiento para tratar fiebre hemorragica virica con proteina c. | |
| ES520293A0 (es) | Procedimiento para la fabricacion de un derivado de azolcarboxamida n,n-subsitutida. | |
| ES542061A0 (es) | Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas | |
| DE3380923D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen. | |
| PT1001942E (pt) | Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem | |
| DK162048C (da) | 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse | |
| MY116362A (en) | Use of selegiline for the treatment of epileptic disorders | |
| DK1133314T3 (da) | Protein C til behandling af seglcellesygdom og thalassæmi | |
| DE3382392D1 (de) | Dosierungsart zur dauerhaften verabreichung von chinidin. | |
| ES8404182A1 (es) | Un metodo de prepara el enantiomero (+) s de secoverin | |
| BR9812265A (pt) | Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias. | |
| TR199801887A2 (xx) | Bir Na+/H+ - de�i�tiricisi inhibit�r�. | |
| ES269732Y (es) | Aspersor para riego perfeccionado. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |